Cargando…
Biomarkers in two different animal models of pulmonary arterial hypertension (PAH) under treatment with a cGMP enhancing substance
Autores principales: | Grupe, Julia, Neumann, Andrea, Stasch, Johannes-Peter, Leineweber, Kirsten |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3363225/ http://dx.doi.org/10.1186/1471-2210-11-S1-P31 |
Ejemplares similares
-
NO/cGMP signalling in platelets
por: Schinner, Elisabeth, et al.
Publicado: (2009) -
Analysis of cGMP signalling with transgenic mice expressing FRET-based cGMP sensors
por: Wen, Lai, et al.
Publicado: (2013) -
NO-cGMP signalling and cancer therapy
por: Bian, Ka, et al.
Publicado: (2013) -
Negative feedback regulation within NO/cGMP pathway attenuates vasodilatory response in renovascular hypertension
por: Mergia, Evanthia, et al.
Publicado: (2009) -
The ANP/cGMP/cGMP-dependent protein kinase pathway counteracts Angiotensin II-stimulated calcium mobilization in cardiac myocytes
por: Klaiber, Michael, et al.
Publicado: (2009)